The ability of kenpaullone to modify parkin recruitment to mitochondria was also investigated in EGFP-PRKN–expressing SH-SY5Y cells, a human neuroblastoma cell line with a dopaminergic phenotype commonly used as a neuronal model. Here, PRKN is linked to neuroblastoma.